Jan M C Junggeburt
Overview
Explore the profile of Jan M C Junggeburt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Courrech Staal E, Wouters M, van Sandick J, Takkenberg M, Smit V, Junggeburt J, et al.
Eur J Cancer
. 2010 Jan;
46(4):720-8.
PMID: 20044247
Objective: To evaluate the prognostic value of the tumour stroma ratio (TSR) in resected adenocarcinoma of the oesophagus. Background: In the literature, a refinement of oesophageal cancer staging has been...
2.
Mesker W, Liefers G, Junggeburt J, van Pelt G, Alberici P, Kuppen P, et al.
Cell Oncol
. 2009 May;
31(3):169-78.
PMID: 19478385
Background: For stage I-II colon cancer a significant number (5-25%) of patients has recurrent disease within 5 years. There is need to identify these high-risk patients as they might benefit...
3.
Heer P, Sandel M, Guertens G, De Boeck G, Koudijs M, Nagelkerke J, et al.
Cancer Chemother Pharmacol
. 2008 Feb;
62(5):811-9.
PMID: 18247029
Introduction: Nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce the risk of colorectal cancer in cyclooxygenase-2 (COX-2) overexpressing colorectal cancers. The present study was designed to evaluate the inhibitory...
4.
Mesker W, Junggeburt J, Szuhai K, Heer P, Morreau H, Tanke H, et al.
Cell Oncol
. 2007 Aug;
29(5):387-98.
PMID: 17726261
Background: Tumor staging insufficiently discriminates between colon cancer patients with poor and better prognosis. We have evaluated, for the primary tumor, if the carcinoma-percentage (CP), as a derivative from the...
5.
Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases
van Duijnhoven F, Jansen M, Junggeburt J, van Hillegersberg R, Rijken A, Van Coevorden F, et al.
Ann Surg Oncol
. 2006 Mar;
13(5):651-8.
PMID: 16538411
Background: The prognosis of patients with colorectal cancer is poor, especially when there is distant metastatic disease. Local ablation of tumor by radiofrequency ablation (RFA) has emerged as a safe...